Zoltan Pataky

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

High Fat Diet Induced

Top Venues

Revue medicale suisse

International journal of obesity (2005)

Acta physiologica (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge César Correia, Maria Mavromati, Zoltan Pataky
[Weight gain during menopause: physiology and practical implications]. Revue medicale suisse 20 (866) (2024)
Florence Somers, Anna Toumanova, Lydia Lanza Von Haller, Sylvie Campos, Minoa K Jung, Zoltan Pataky
[Nutrition-obesity. New program about behavioural issues involved in weight loss through surgery]. Revue medicale suisse 20 (856-7) (2024)
Jorge César Correia, Zoltan Pataky
[The evolution of the perception of obesity: the "weight" of social norms]. Revue medicale suisse 19 (819) (2023)
Géraldine Coppin, David Muñoz Tord, Eva R Pool, Loïc Locatelli, Amal Achaibou, Asli Erdemli, Laura León Pérez, Lavinia Wuensch, Donato Cereghetti, Alain Golay, David Sander, Zoltan Pataky
A randomized controlled trial investigating the effect of liraglutide on self-reported liking and neural responses to food stimuli in participants with obesity. International journal of obesity (2005) (2023)
Jorge César Correia, Ahmed Waqas, Soo Huat Teoh, Karim Gariani, François R Jornayvaz, Alain Golay, Zoltan Pataky
Effectiveness of Therapeutic Patient Education Interventions in Obesity and Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 14 (18) (2022)
J Thomas Hannich, Ursula Loizides-Mangold, Flore Sinturel, Takeshi Harayama, Bart Vandereycken, Camille Saini, Pauline Gosselin, Marie-Claude Brulhart-Meynet, Maud Robert, Stephanie Chanon, Christine Durand, Jonathan Paz Montoya, Fabrice P A David, Idris Guessous, Zoltan Pataky, Alain Golay, François R Jornayvaz, Jacques Philippe, Emmanouil T Dermitzakis, Steven A Brown, Etienne Lefai, Howard Riezman, Charna Dibner
Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients. Acta physiologica (Oxford, England) 232 (1) (2021)